Our results documented that the expression of DGAT1 and DGAT2 decreased significantly in ccRCC cells when RNASET2 was knocked down, whereas when RNASET2 was overexpressed, the expression of DGAT1 and DGAT2 increased significantly. This evidence concerns the gene RNASET2 and nonpapillary renal cell carcinoma.